Novel noninvasive identification of biomarkers by analytical profiling of chronic wounds using volatile organic compounds

Cellular events and biomarkers of wound healing

Researchers have identified several of the cellular events associated with wound healing. Platelets, neutrophils, macrophages, and fibroblasts primarily contribute to the process. They release cytokines including interleukins (ILs) and TNF-α, and growth factors, of which platelet-derived growth factor (PDGF) is perhaps the most important. The cytokines and growth factors manipulate the inflammatory phase of healing. Cytokines are chemotactic for white cells and fibroblasts, while the growth factors initiate fibroblast and keratinocyte proliferation. Inflammation is followed by the proliferation of fibroblasts, which lay down the extracellular matrix. Simultaneously, various white cells and other connective tissue cells release both the matrix metalloproteinases (MMPs) and the tissue inhibitors of these metalloproteinases (TIMPs). MMPs remove damaged structural proteins such as collagen, while the fibroblasts lay down fresh extracellular matrix proteins. Fluid collected from acute, healing wounds contains growth factors, and stimulates fibroblast proliferation, but fluid collected from chronic, nonhealing wounds does not. Fibroblasts from chronic wounds do not respond to chronic wound fluid, probably because the fibroblasts of these wounds have lost the receptors that respond to cytokines and growth factors. Nonhealing wounds contain high levels of IL1, IL6, and MMPs, and an abnormally high MMP/TIMP ratio. Clinical examination of wounds inconsistently predicts which wounds will heal when procedures like secondary closure are planned. Surgeons therefore hope that these chemicals can be used as biomarkers of wounds which have impaired ability to heal. There is also evidence that the application of growth factors like PDGF will help the healing of chronic, nonhealing wounds.

In vivo solid-phase microextraction for tissue bioanalysis

Conventional in vitro or ex vivo bioanalytical quantitative sample preparation methods for the determination of compounds in biological tissues are often coupled with challenges in obtaining an assay representative of the system of interest. The rising interest in in vivo microsampling bioanalytical methods is due to the unique advantages they offer over their in vitro counterparts. In vivo solid-phase microextraction (SPME), a diffusion-based microsampling tool, has been successfully applied in recent studies to various biological systems. This review presents recent trends in tissue bioanalysis using in vivo SPME as a sample preparation tool. Efforts were made to discuss the various bioapplications of the method while highlighting possible strategies for improved sensitivity where needed. In vivo SPME devices currently employed for the various applications have also been described. In addition, we highlight selectivity of a new class of biocompatible coatings that can potentially improve the coverage of metabolites for untargeted metabolomics.